<a href="https://laohu8.com/S/SXTPW">60 Degrees</a> Pharmaceuticals Announces $5 Million Public Offering with Potential Additional $5 Million from Warrant Exercises
60 Degrees Pharmaceuticals Inc., a company focused on developing new medicines for infectious diseases, has announced the pricing of a public offering involving 2,631,578 shares of its common stock. This offering includes accompanying Series A-1 warrants and short-term Series A-2 warrants to purchase an equal number of shares, priced at $1.90 per share of common stock. The company anticipates gross proceeds of approximately $5 million from the offering, with the possibility of an additional $5 million if the short-term Series A-2 warrants are fully exercised on a cash basis. H.C. Wainwright & Co. is serving as the exclusive placement agent for the offering. The proceeds are intended for working capital and general corporate purposes.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 60 Degrees Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-065718), on July 18, 2025, and is solely responsible for the information contained therein.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。